Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 4
2015 1
2016 1
2020 2
2021 4
2022 4
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial.
Dizman N, Meza L, Bergerot P, Alcantara M, Dorff T, Lyou Y, Frankel P, Cui Y, Mira V, Llamas M, Hsu J, Zengin Z, Salgia N, Salgia S, Malhotra J, Chawla N, Chehrazi-Raffle A, Muddasani R, Gillece J, Reining L, Trent J, Takahashi M, Oka K, Higashi S, Kortylewski M, Highlander SK, Pal SK. Dizman N, et al. Among authors: chawla n. Nat Med. 2022 Apr;28(4):704-712. doi: 10.1038/s41591-022-01694-6. Epub 2022 Feb 28. Nat Med. 2022. PMID: 35228755 Free PMC article. Clinical Trial.
Cytoreductive Nephrectomy in 2021: Obsolete.
Meza L, Chawla NS, Giannarini G, Pal SK. Meza L, et al. Among authors: chawla ns. Eur Urol Open Sci. 2021 Dec 29;36:44-46. doi: 10.1016/j.euros.2021.09.021. eCollection 2022 Feb. Eur Urol Open Sci. 2021. PMID: 34988492 Free PMC article. No abstract available.
An Update on the Treatment of Papillary Renal Cell Carcinoma.
Chawla NS, Sayegh N, Prajapati S, Chan E, Pal SK, Chehrazi-Raffle A. Chawla NS, et al. Cancers (Basel). 2023 Jan 17;15(3):565. doi: 10.3390/cancers15030565. Cancers (Basel). 2023. PMID: 36765524 Free PMC article. Review.
MET receptor in oncology: From biomarker to therapeutic target.
Malik R, Mambetsariev I, Fricke J, Chawla N, Nam A, Pharaon R, Salgia R. Malik R, et al. Among authors: chawla n. Adv Cancer Res. 2020;147:259-301. doi: 10.1016/bs.acr.2020.04.006. Epub 2020 Jun 17. Adv Cancer Res. 2020. PMID: 32593403 Review.
Genomic and Clinical Prognostic Factors in Patients With Advanced Urothelial Carcinoma Receiving Immune Checkpoint Inhibitors.
Chawla NS, Sayegh N, Tripathi N, Govindarajan A, Zengin ZB, Phillip EJ, Dizman N, Meza L, Muddasani R, Chehrazi-Raffle A, Malhotra J, Hsu J, Agarwal N, Pal SK, Tripathi A. Chawla NS, et al. Clin Genitourin Cancer. 2023 Feb;21(1):69-75. doi: 10.1016/j.clgc.2022.11.007. Epub 2022 Nov 18. Clin Genitourin Cancer. 2023. PMID: 36509613
Real-World Outcomes of Latinx Versus Non-Latinx Patients Treated With First-Line Immunotherapy for Metastatic Renal-Cell Carcinoma.
Chehrazi-Raffle A, Leong S, Ali S, Kim T, Melamed S, Li X, Zengin Z, Meza L, Chawla N, Govindarajan A, Castro D, Mercier B, Ebrahimi H, Dizman N, Tripathi N, Sayegh N, Rock A, Yeh J, Pal SK, Onyshchenko M. Chehrazi-Raffle A, et al. Among authors: chawla n. Oncologist. 2023 Dec 11;28(12):1079-1084. doi: 10.1093/oncolo/oyad190. Oncologist. 2023. PMID: 37432304 Free PMC article.
Ultrasensitive Circulating Tumor DNA Pilot Study Distinguishes Complete Response and Partial Response With Immunotherapy in Patients With Metastatic Renal Cell Carcinoma.
Chehrazi-Raffle A, Muddasani R, Dizman N, Hsu J, Meza L, Zengin ZB, Malhotra J, Chawla N, Dorff T, Contente-Cuomo T, Dinwiddie D, McDonald BR, McDaniel T, Trent JM, Baehner FL, Murtaza M, Pal SK. Chehrazi-Raffle A, et al. Among authors: chawla n. JCO Precis Oncol. 2023 Apr;7:e2200543. doi: 10.1200/PO.22.00543. JCO Precis Oncol. 2023. PMID: 37027813 Free PMC article.
26 results